TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes.

Stefan Kommoss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.